Sitemap EUCAST - Home About EUCAST Organisation Steering Committee General Committee EUCAST Statutes National AST Committees (NAC) Network Laboratories Development Laboratories (EDL) Subcommittees Antimycobacterial Susceptibility Testing (AMST) Antifungal Susceptibility Testing (AFST) Veterinary…
Get to know moreBreakpoints for Rapid AST Breakpoints validated for EUCAST short incubation disk diffusion directly from positive blood culture bottles. For interpretation of rapid AST directly from blood culture bottles, reading and interpreting inhibition zones after 4 hours, 6 hours, 8 hours and 16-20 hours,…
Get to know moreAbout Clinical Breakpoint Tables Clinical breakpoints are for everyday use to advise on patient therapy. Breakpoint tables are updated on the 1st of January each year. Tentative new tables are published in early December - this is for consultation and to permit laboratories to prepare for changes.…
Get to know moreWhen there are no breakpoints? When there are no breakpoints? Guidance document, 29 September 2024 Download PDF Sometimes breakpoints for a species and/or an agent are lacking in EUCAST tables. This may happen because data to allow setting breakpoints is lacking, especially for rare species;…
Get to know morePublic Consultations Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated. Current public consultations Subject Dates Description Carbapenem susceptibility testing and reporting -…
Get to know moreDocument Archive Breakpoint tables QC tables Guidance documents Expert rules Rationale documents Disk diffusion methodology Disk diffusion validation RAST Expected phenotypes Broth microdilution Clinical breakpoints (v 14.0) - file for printing (1 Jan, 2024 - 31 Dec 2024) Clinical breakpoints (v…
Get to know moreDevelopment of Clinical Breakpoints and ECOFFs These pages collate information on the definition of clinical breakpoints and the process of setting MIC breakpoints. Background information is given in the Rationale Documents and in Public Consultations and the MIC:ZD (MIC vs. zone diameter)…
Get to know moreClinical Breakpoint Tables Breakpoints are part of a system for categorizing microorganisms as: Susceptible (S) Susceptible, increased exposure (I) Resistant (R) To antimicrobial agents approved for use in the treatment of infectious diseases. Information of the structure of the tables and how they…
Get to know moreSetting Breakpoints Breakpoints for phenotypic antimicrobial susceptibility testing have been determined by breakpoint committees and as part of regulatory processes for the approval of new drugs since the 1970s. Knowledge of dosage, modes of administration, target infections and clinical outcome…
Get to know moreClinical breakpoint table (Yeast and moulds) Breakpoints and methods for susceptibility testing of yeasts, moulds and dermatophytes are developed and validated by the EUCAST subcommittee on AFST. Document Description Clinical breakpoints for fungi v. 12.0 PDF file for printing; valid from 26 June,…
Get to know more
We’ve prepared a short video to help you get familiar with the new layout and features.